Thioredoxin-Interacting Protein as a Novel Potential Therapeutic Target in Diabetes Mellitus and Its Underlying Complications
Dawit Zewdu Wondafrash,1 Asmelash Tesfay Nire’a,2 Gebrehiwot Gebremedihn Tafere,1 Desilu Mahari Desta,3 Demoze Asmerom Berhe,4 Kaleab Alemayehu Zewdie1 1Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, Ethiopia; 2Pharmacology and Toxicology Resear...
Guardado en:
Autores principales: | Wondafrash DZ, Nire'a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e120ff783cf64328b3bfcada75f0a2d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Emerging Role of Metabolism in Brain-Heart Axis: New Challenge for the Therapy and Prevention of Alzheimer Disease. May Thioredoxin Interacting Protein (TXNIP) Play a Role?
por: Lorena Perrone, et al.
Publicado: (2021) -
Early Predictors in the Onset of Type 2 Diabetes at Different Fasting Blood Glucose Levels
por: Xie X, et al.
Publicado: (2021) -
Qihu Preparation Ameliorates Diabetes by Activating the AMPK Signaling Pathway in db/db Mice
por: Zeng H, et al.
Publicado: (2021) -
Jinmaitong Ameliorates Diabetic Peripheral Neuropathy Through Suppressing TXNIP/NLRP3 Inflammasome Activation In The Streptozotocin-Induced Diabetic Rat Model
por: Sun Q, et al.
Publicado: (2019) -
Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere GG, et al.
Publicado: (2020)